Wei Ah und Acute Myeloid Leukemia - Info zur Person

(1 - 8 von 19

)

Azacitidine and Venetoclax in Previously Untreated Acute ...New England Journal of Medicine

www.nejm.org

von CD DiNardo · · Zitiert von: — DiNardo CD, Wei AH. How I treat acute myeloid leukemia in the era of new drugs. Blood 2020;135: Go to Citation. Crossref · PubMed · ISI. von CD DiNardo · · Zitiert von: — DiNardo CD, Wei AH. How I treat acute myeloid leukemia in the era of new drugs. Blood 2020;135: Go to Citation. Crossref · PubMed · ISI.

Alle Infos zum Namen "Wei Ah"

Chemotherapy and Venetoclax in Elderly Acute Myeloid ...ASCO Publications

ascopubs.org

von CC Chua · · Zitiert von: 134 — Wei AH, Strickland SA Jr, Hou J-Z, et al: Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia ... von CC Chua · · Zitiert von: 134 — Wei AH, Strickland SA Jr, Hou J-Z, et al: Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia ...

Oral Azacitidine (CC-486) for the Treatment of Myeloid ...Clinical Lymphoma, Myeloma and Leukemia

www.clinical-lymphoma-myeloma-leukemia.com

von G Garcia-Manero · · Zitiert von: 16 — 83. Roboz GJ, Ravandi F, Wei AH, et al. CC-486 prolongs survival for patients with Acute Myeloid Leukemia (AML) ... von G Garcia-Manero · · Zitiert von: 16 — 83. Roboz GJ, Ravandi F, Wei AH, et al. CC-486 prolongs survival for patients with Acute Myeloid Leukemia (AML) ...

Oral Azacitidine Maintenance Therapy for Acute Myeloid ...Europe PMC

europepmc.org

von AH Wei · · Zitiert von: 330 — Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission. Wei AH 1 ,. Döhner H ... von AH Wei · · Zitiert von: 330 — Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission. Wei AH 1 ,. Döhner H ...

Prof Andrew Wei, Lab Head | WEHI Researcher ProfileWalter and Eliza Hall Institute of Medical Research

www.wehi.edu.au

... Wei AH, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. New Engl J Med 2020;383(7): PMID: Stone RM Wei AH, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. New Engl J Med 2020;383(7): PMID: Stone RM ...

Research publicationsAlfred Health

www.alfredhealth.org.au

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, ... Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, ...

Paper: Acute Myeloid Leukemia Driven IL- ...The Conference Exchange

ash.confex.com

— Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, et al. Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive — Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, et al. Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive ...

Sustained Survival Benefit Seen With Oral Azacitidine as ...Cancer Network

www.cancernetwork.com

— Wei AH, Döhner H, Sayar H, et al. Long-term overall survival (OS) with oral azacitidine (oral-AZA) in patients with acute myeloid leukemia — Wei AH, Döhner H, Sayar H, et al. Long-term overall survival (OS) with oral azacitidine (oral-AZA) in patients with acute myeloid leukemia ...

Verwandte Suchanfragen zu Wei Ah

Personen
Vorname "Wei" (618)
Name

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Wei Ah und Acute Myeloid Leukemia Person-Info